Immunotherapy-induced sialadenitis: sjögren's syndrome or a new sialadenitis.
Although immune checkpoint inhibitors (ICIs) have improved survival in head and neck squamous cell carcinoma (HNSCC), associated adverse events, such as sialadenitis, remain poorly characterized. This study aimed to define the clinicopathological features, establish the causal p…